tiprankstipranks
Trending News
More News >
Cutia Therapeutics (HK:2487)
:2487
Hong Kong Market

Cutia Therapeutics (2487) Income Statement

Compare
0 Followers

Cutia Therapeutics Income Statement

Last quarter (Q4 2024), Cutia Therapeutics's total revenue was ¥92.02M, an increase of 78.20% from the same quarter last year. In Q4, Cutia Therapeutics's net income was ¥-116.44M. See Cutia Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21
Total Revenue
¥ 279.62M¥ 137.62M¥ 11.37M¥ 2.04M
Gross Profit
¥ 143.46M¥ 71.01M¥ 7.94M¥ 1.61M
Operating Expenses
¥ 598.61M¥ 71.01M¥ 310.89M¥ 178.41M
Depreciation and Amortization
¥ 30.85M¥ 42.48M¥ 18.92M¥ 9.79M
EBITDA
¥ -430.69M¥ -1.92B¥ -535.19M¥ -309.23M
Operating Income
¥ -455.15M¥ -539.65M¥ -538.28M¥ -313.98M
Other Income/Expenses
¥ 21.34M¥ -1.42B¥ -246.63M¥ -139.60M
Pretax Income
¥ -433.81M¥ -1.96B¥ -555.84M¥ -319.58M
Net Income
¥ -433.81M¥ -1.96B¥ -555.84M¥ -319.58M
Per Share Metrics
Basic EPS
¥ -1.41¥ -9.60¥ -6.94¥ -3.99
Diluted EPS
¥ -1.41¥ -9.60¥ -6.94¥ -3.99
Weighted Average Shares Outstanding
307.19M 204.61M 80.05M 80.05M
Weighted Average Shares Outstanding (Diluted)
307.19M 204.61M 80.05M 80.05M
Currency in CNY

Cutia Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis